October 21, 2010 – For the first time, a hospital in the United Kingdom will offer women osteoporosis detection and mammography in a single exam. Sectra reached an agreement with Aspen Healthcare to use Sectra’s screening tools at the Holly House Hospital.

The initiative could also drastically reduce care costs, since fractures caused by osteoporosis will decline.

“For most women, regular mammography examinations are a natural part of the safety net for early detection of breast cancer. The ability to conduct screening to identify osteoporosis at the same time could mean that many women will avoid unnecessary suffering and could result in major cost-savings for society,” said Torbjörn Kronander, president of Sectra’s medical operations.

Based on a single radiology image of the hand, taken in connection with the mammography examination and using the same equipment, the Sectra dxr-online service calculates bone mineral density. To perform the combined examination, Holly House has invested in Sectra MicroDose Mammography, which with superior image quality, generates the lowest radiation dose available. Sectra MicroDose Mammography is currently awaiting approval from the U.S. Food and Drug Administration (FDA).

“We are extremely excited to be using these exceptional technologies for our mammography and osteoporosis services. The dxr-online service has enabled us to safely monitor patients’ bone mineral density on a regular basis providing early indication of the risk of developing osteoporosis and therefore giving the patient the opportunity for a better quality of life,” said Allyson Budino, manager of the diagnostic centre at Holly House Hospital.

Osteoporosis-related fractures remain one of the major health threats for women. But if women in the risk zone for osteoporosis are identified at an early stage, there are now inexpensive and effective ways of preventing fractures through lifestyle changes and medication.

For more information: www.sectra.com


Related Content

News | Breast Imaging | Washington University

Jan. 22, 2026 — In breast cancer, a biopsy is the only diagnostic procedure that can determine if a suspicious lump or ...

Time January 29, 2026
arrow
News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
News | Mammography

Jan. 16, 2026 — Vega Imaging Informatics has announced the successful curation of the world’s largest digital breast ...

Time January 19, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — VizMark has received U.S. Food and Drug Administration FDA 510k clearance for VM1, a non-metal visual ...

Time January 19, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — Susan G. Komen, the world’s leading breast cancer organization commends Assemblymember Lori Wilson (D ...

Time January 16, 2026
arrow
News | Breast Imaging

Jan. 14, 2026 — iSono Health has announced the commercial launch of ATUSA, an FDA-cleared, wearable and automated 3D ...

Time January 14, 2026
arrow
Feature | Cybersecurity | Kyle Hardner

As radiology practices shift toward cloud-based platforms and integrate AI-powered tools, will practices become more ...

Time January 14, 2026
arrow
News | Women's Health

Dec. 12. 2025 — A new study has found that an individualized approach to breast cancer screening that assesses patients’ ...

Time December 17, 2025
arrow
News | Breast Imaging

Dec. 16, 2025 — Hologic, Inc, a medical technology company dedicated to improving women’s health, recently announced new ...

Time December 16, 2025
arrow
News | FDA

Dec. 8, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, has submitted a 510(k) premarket ...

Time December 08, 2025
arrow
Subscribe Now